Home > Dow Jumps 210 Points On Vaccine News From AstraZeneca

News
Dow Jumps 210 Points On Vaccine News From AstraZeneca

Description

On Monday, US stocks rose. AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%. This is the third COVID-19 vaccine said to have surpassed the Food and Drug Administration's requirement of 50% effectiveness. S&P 500: 3,580.82, up 0.7% Dow Jones industrial average: 29,473.41, up 0.7% (210 points) Nasdaq composite: 11,929.04, up 0.6%

Added on the 23/11/2020 11:15:29 - Copyright : Wochit

To customise your video :

Or Create an account

More videos on the subject

  • Dow Up Over 200 Points On Anticipation Of Stimulus

    On Monday, US stocks rallied as investors bet on the distribution of Pfizer's COVID-19 vaccine and stimulus progress to lift the economy. According to Business Insider, a bipartisan $908 billion stimulus proposal is set to be formally unveiled on Monday. One package will include $748 billion in funds for highly supported measures. A smaller package including more controversial state and local government aid and liability protections for businesses. On Monday, Pfizer and BioNTech will deliver their coronavirus vaccine. Oil prices ticked higher after a tanker exploded in a Saudi Arabian port. West Texas Intermediate crude gained as much as 1.9%, to $47.44 per barrel.

    14/12/2020 - Wochit
  • Dow Jones surges 1,300 points after Pfizer announces its Covid-19 vaccine is 90% effective

    New York (USA), Nov 9 (EFE / EPA), (Camera: Alba Vigaray).- US stocks rocketed on Monday after American pharmaceutical giant Pfizer announced that its candidate Covid-19 vaccine was 90% effective.FOOTAGE OF NEW YORK STOCK EXCHANGE

    09/11/2020 - EFE Inglés
  • Netflix Drops 9% After Vaccine News

    On Monday, phrama giant Pfizer revealed positive COVID-19 vaccine news. The news sent shares of stay-at-home stocks like Netflix plummeting on Monday. Netflix itself fell as much as 9%, even as major indexes like the S&P 500 and Dow Jones industrial average soared to record highs. Consumers flocked to entertainment alternatives amid the lengthy stay-at-home orders. Netflix saw a spike in subscribers due to the COVID-19 pandemic.

    09/11/2020 - Wochit
  • COVID: Valneva's vaccine could be superior to AstraZeneca, new trial reveals

    On en parle : Emission du jeudi 20 novembre 2014

    18/10/2021 - Wochit

More videosNews

Watch video of  - DemainEntreprendre - épisode 12 - Label : Economie wallonne -
News

DemainEntreprendre - épisode 12

29/04/2021 12:55:32